Drug: NAPROSYN Injury: Muscular weakness Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
116588023 | NAPROSYN | Muscular weakness | ROCHE | 66.00 YR | M | 0 | 20160815 | CA |
122683973 | NAPROSYN | Muscular weakness | JANSSEN | 76.00 YR | M | 79 KG | 20160808 | US |
124444222 | NAPROSYN | Muscular weakness | ENDO | 76.00 YR | M | 79 KG | 20160811 | US |
125215432 | NAPROSYN | Muscular weakness | ASTELLAS | 76.00 YR | M | 0 | 20160720 | US |
125588041 | NAPROSYN | Muscular weakness | AMGEN | 66.00 YR | M | 0 | 20160715 | CA |
125829161 | NAPROSYN | Muscular weakness | PFIZER | 66.00 YR | M | 0 | 20160722 | CA |
126274391 | NAPROSYN | Muscular weakness | INTERCHEM | 66.00 YR | M | 0 | 20160805 | CA |
Total Records: 7 Number of Pages: 1